Fibromyalgia and Migraine, Two Faces of the Same Mechanism
In this study fibromyalgia sufferers were randomly administered a combination of monoamine -oxidase inhibitors (MAOIs) -A/B with 5-HTP, 5-HTP alone, MAOIs-A/B alone, or the tricyclic drug amitriptyline in order to compare the efficacy of these treatments. The benefits on the painful syndrome were assessed by using Visual Analogic Scale score rating from 0 to 4. The combination of MAOIs with 5-HTP significantly improved fibromyalgia syndrome as determined by Visual Analogic Scale whereas the other treatments yielded poorer benefits. No subject withdrew from the trial due to adverse effects, even if some sleep disturbances and mild stomach-ache were reported. The tolerability of the association MAOIs/5-HTP was good, although a transient cheese effect occurred in one of the patients treated with MAOIs as well as in a patient treated with the association MAOIs and 5-HTP. No one of these two cases was due to pharmacological dietetic mistake of the patient. In both the cases the transient hypertension was associated to very dramatic emotional events.
The benefits obtained by using the combination of MAOIs with 5-HTP can be explained with a treatment-induced enhancement of aminergic and serotonergic transmission. The recently shown high prevalence of migraine in the population of fibromyalgia sufferers, suggests a common ground shared by fibromyalgia and migraine. Migraine has been demonstrated to be characterized by a defect in the serotonergic and adrenergic systems. A parallel dramatic failure of serotonergic systems and a defect of adrenergic transmission have been evidenced to affect fibromyalgia sufferers too. Enhancing serotonergic analgesia while increasing adrenergically mediated analgesia seems to be an important tool in fibromyalgia. Treatment consisting with the association MAOIs/5-HTP is aimed at enhancing serotonergic/adrenergic transmission by inducing an up-regulation of serotonergic/adrenergic receptors and a simultaneous increase of serotonin levels in the central nervous system.
KeywordsMigraine Serotonin Tryptophan Monoamine Fibromyalgia
Unable to display preview. Download preview PDF.
- Boulton, A. A., Juorrio, A.V., Peterson, I.A., 1990, Phenylethylamine in the CNS: effects ofmonoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission. J Neural Trans29: 119Google Scholar
- Cremata, V,Y Koe, B.K., 1966, Clinical pharmacological evaluation of p-chlorophenylalanine: a new serotonin-depleting agent. Clin Pharmacol Ther7: 768Google Scholar
- Curzon, G., 1979, Relationship between plasma, CSF and brain tryptophan. J Neural Transm15: 81Google Scholar
- Handworker, H.O., 1993, Mechanisms of cutaneous and subcutaneous hyperalgesia, in “New Trends in Referred Pain and Hyperalgesia”, Vecchiet L, Albe-Fessard D, Lindblom U, eds, Elsevier, Amsterdam (1993)Google Scholar
- International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1998, 8 (7)Google Scholar
- Lance, J.W ., 1992, Possible role of serotonin in the migraine syndrome, in: “Advances in Pain Research and Therapy”, Sicuteri F., Terenius L., Vecchiet L., Maggi CA.,eds, Raven Press, New YorkGoogle Scholar
- Mc Cain, G.A., 1990, Management of fibromyalgia syndrome. In: JR Fricton, A Essam (eds), Advances in Pain Research and Therapy, Vol 17, Raven Press, New YorkGoogle Scholar
- Munoz, M., Dumas, M., Boutros-Toni, F, Coquelle, D., Nicolas, A., Ndzanga, E„ Boa, F, Vallat, J.M., Dartigues, J.F., 1993, Prevalence of headache in a representative sample of the population in a French department (Haute-Vienne-Limousin) Headache33 (10) 521Google Scholar
- Nicolodi, M., Sicuteri, F., 1992, Central panalgia as an expression of systemic analgodeficiency. in: “Advances in Pain Research and Therapy”, F. Sicuteri, L Terenius, L Vecchiet, C A Maggi, eds, Raven Press, New YorkGoogle Scholar
- Rajiv, J., Welch, K.M.A., D’Andrea, G., 1989, Serotonergic hypofiinction in migraine: a synthesis of evidence based on platelet dense body dysfunction. Cephalalgia9: 18Google Scholar
- Sicuteri, F., Michelacci, S,. Franchi, G., 1962, Contributo alia caratterizzazione della farmacologia della reserpina sul sistema nervoso centrale. antagonismo di un bloccante adrenergico sul fenomeno dell’eccitazione paradossa da reserpina nel topo. Boll Soc Ital Biol Sper38 (8): 381Google Scholar
- Sicuteri, F., Fanciullacci, M., Del Bianco, PL., 1965, Variata reattivita alia 5-idrossitriptamina ed alia nor-adrenalina da anti monoamino ossidasici nell’ uomo. Boll Soc Ital Biol Sper41 (9): 467Google Scholar
- Sicuteri, F., Fanciullacci, M., Del Bianco, P.L., 1965, Variata reattivita alia 5-idrossitriptamina ed alia nor-adrenalina da anti monoamino ossidasici nell’ uomo. Boll Soc Ital Biol Sper41 (9): 467Google Scholar
- Sicuteri, F., Anselmi, B., Fanciullacci, M., 1974, The serotonin (5-HT) theory of migraine. Adv Neurol4: 383Google Scholar
- Sicuteri, F., Nicolodi, M., Fusco, B.M., 1984, Abnormal sensitivity to agonists, antagonists and releasers, in: “Basic Mechanism of headache”, JOlesen, L Edvinnsson, eds, Elsevier, AmsterdamGoogle Scholar
- Sicuteri, F., Nicolodi, M., 1991, Serotonin: a “Sphynx” in migraine, in, “Headache and depression: serotonin pathways as a common clue”, Nappi G et al., eds, Raven Press, New YorkGoogle Scholar
- Simons, D ., 1990, Muscular pain syndromes, in: “Advances in Pain Research and Therapy”, JR Fricton, A Essam,eds, Raven Press, New YorkGoogle Scholar
- Wang, R.I.H., Wiesen, R.L., Treul, S., Stockdale, S., 1976, Brief anxiety rating test J Clin Pharmacol16 (2/3): 99 - 105Google Scholar
- Zung, WW . 1965 A self rating depression scale. Arch Gen Psychiatry12: 163–65Google Scholar